Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Karyopharm Therapeutics (KPTI) Prices Upsized 2.65M Common Offering at $42.50/Share
June 27, 2014 6:13 AM EDTKaryopharm Therapeutics (Nasdaq: KPTI) announced the pricing of its underwritten public offering of 2,647,247 shares of its common stock at a price of $42.50 per share before underwriting discounts. Karyopharm is selling 2,447,247 shares of its common stock in this offering, and certain existing stockholders are... More
Karyopharm Therapeutics (KPTI) Commences 2.2M Common Stock Offering
June 25, 2014 4:02 PM EDTKaryopharm Therapeutics (NASDAQ: KPTI) announced that it has commenced an underwritten public offering of 2,200,000 shares of its common stock. The offering is expected to consist of 2,000,000 shares to be offered by Karyopharm and 200,000 shares to be offered by existing stockholders. Karyopharm will... More
